Barnhart, J.W., et al., The Synthesis, Metabolism, and Biological Activity of Probucol and its Analogs, Pharmacochem. Libr. No. 17, (1991), pp. 277-299. |
BioCentury Extra (The Bernstein Report of BioBusiness), “AtheroGenics: Faster than Anticipated,” (Reprint from May 29, 2001). |
Chemical Abstracts Service, Columbus, Ohio, US; STN, Chemical Abstracts, 28-Heterocyclic Compounds (More Than One Hetero Atom), vol. 124, No. 1, 1996, p. 921. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, Chemical Abstracts, 28-Heterocyclic Compounds (More Than One Hetero Atom), vol. 124, No. 11, 1996, p. 1251. |
Cominacini et al., Antioxidants Inhibit the Expression of Intercellular Cell Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 Induced by Oxidized LDL on Human Umbilical Vein Endothelial Cells, Free Radical Biology & Medicine, vol. 22, Nos. 1/2, pp. 117-127, 1997. |
DeMeglio, P. et al., Farmaco, Ed. Sci., 40(11), 833-844 (1985) (partial English language translation). |
Feldman et al., The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881, Atherosclerosis, vol. 144, No. 2 (Jun. 1999), p. 343-355. |
Press Release, Nov. 12, 2001, “AtheroGenics Announces Positive Phase II Results From CART-1 Clinical Trial For Restenosis”. |
Fruebis et al., A Comparison of the Antiatherogenic Effects of Probucol and of a Structural Analogue of Probucol in Low Density Lipoprotein Receptor-deficient Rabbits, J. Clin. Invest., vol. 94, Jul. 1994, pp. 392-398. |
Gershbein et al., Ation of Drugs and Chemical Agents on Rat Liver Regeneration, Drug and Cheical Toxicology, 8(3), 125-143 (1985). |
Chemical Abstracts Service, Columbus, Ohio, US; STN, accession No. 122:187387J, see abstract, Kobayashi et al., vol. 122, 1995. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, accession No. 94:30290c, see abstract, Mamedov et al., vol. 94, 1981. |
Mao et al., Attenuation of Atherosclerosis in a Modified Strain of Hypercholesterolemic Watanabe Rabbits With Use of a Probucol Analogue (MDL 29,311) That Does Not Lower Serum Cholesterol, Arteriosclerosis and Thrombosis, vol. 11, No. 4, Jul./Aug. 1991. |
Mao et al., Antioxidant Activity of Probucol and Its Analogues in Hypercholesterolemic Watanabe Rabbits, Journal of Medicinal Chemistry, 1991, vol. 34, pp. 298-302. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, accession No. 86:5066m, see abstract; MEDVEDEV et al., vol. 86, 1997, p. 437. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, accession No. 1970:445047, XP002124423; see abstract; Neuworth et al., J. Med. Chem., (1970), vol. 13, No. 4, 722-725. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, accession No. 110:212254a, see abstract; Pastor et al., vol. 110, 1989. |
Ramasamy et al., Modulation of Expression of Endothelial Nitric Oxide Synthase by Nordihydroguaiaretic Acid, a Phenolic Antioxidant in Cultured Endothelial Cells, Modlecular Pharmacology, vol. 56, No. 1, Jul. 1999, pp. 116-123. |
Roberts et al., Regulation of monocyte to macrophage differentiation by antiglucocorticoids and antioxidants, American Journal of Obstetrics and Gynecology, vol. 179, No. 2, Aug. 1998, pp. 354-362. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, see abstract; Tomich et al., vol. 127, No. 6, 1997. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, accession No. 126:277465v, see abstract, Toshiaki et al., vol. 126, No. 21, 1997, p. 669. |
Chemical Abstracts Service, Columbus, Ohio, US; STN, accession No. 86189w, see abstract; Wagner, Jr., et al., vol. 82, 1975. |